Literature DB >> 20464582

Is chronic migraine a primary or a secondary condition?

Vincenzo Bonavita1, Roberto De Simone.   

Abstract

In the light of the pathophysiologic knowledge acquired in recent years, a tentative redefinition of some types of headache, until now defined as primary, is now possible. Chronic migraine is proposed here as the consequence of "processes" to be ascribed to mechanisms activated by comorbid conditions. The observations supporting the possibility that allodynia represents the process leading to pain progression, which occurs in some migraineurs, are discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20464582     DOI: 10.1007/s10072-010-0272-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  60 in total

1.  Identifying cutaneous allodynia in chronic migraine using a practical clinical method.

Authors:  A Ashkenazi; M Sholtzow; J W Shaw; R Burstein; W B Young
Journal:  Cephalalgia       Date:  2007-02       Impact factor: 6.292

Review 2.  Risk factors for headache chronification.

Authors:  Ann I Scher; Lynn A Midgette; Richard B Lipton
Journal:  Headache       Date:  2008-01       Impact factor: 5.887

3.  Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures.

Authors:  I Ayzenberg; M Obermann; P Nyhuis; M Gastpar; V Limmroth; H C Diener; H Kaube; Z Katsarava
Journal:  Cephalalgia       Date:  2006-09       Impact factor: 6.292

4.  Depression and anxiety disorders associated with headache frequency. The Nord-Trøndelag Health Study.

Authors:  J-A Zwart; G Dyb; K Hagen; K J Ødegård; A A Dahl; G Bovim; L J Stovner
Journal:  Eur J Neurol       Date:  2003-03       Impact factor: 6.089

5.  Cephalic venous congestion aggravates only migraine-type headaches.

Authors:  C-H Chou; A-C Chao; S-R Lu; H-H Hu; S-J Wang
Journal:  Cephalalgia       Date:  2004-11       Impact factor: 6.292

6.  Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine.

Authors:  D S S Vieira; M R Masruha; A L Gonçalves; E Zukerman; C A Senne Soares; M da Graça Naffah-Mazzacoratti; M F P Peres
Journal:  Cephalalgia       Date:  2008-03-31       Impact factor: 6.292

7.  Migraine aggravation caused by cephalic venous congestion.

Authors:  Florian Doepp; Stephan J Schreiber; Jens P Dreier; Karl M Einhäupl; José M Valdueza
Journal:  Headache       Date:  2003-02       Impact factor: 5.887

8.  Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia.

Authors:  M Obermann; M-S Yoon; D Ese; M Maschke; H Kaube; H-C Diener; Z Katsarava
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

Review 9.  Obesity, migraine, and chronic migraine: possible mechanisms of interaction.

Authors:  Marcelo E Bigal; Richard B Lipton; Philip R Holland; Peter J Goadsby
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

Review 10.  Migraine and depression.

Authors:  F Frediani; V Villani
Journal:  Neurol Sci       Date:  2007-05       Impact factor: 3.307

View more
  4 in total

1.  The role of intracranial hypertension in the chronification of migraine.

Authors:  R De Simone; A Ranieri
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

2.  The lesson of chronic migraine.

Authors:  V Bonavita; R De Simone
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

Review 3.  Pain cognition in migraine: from basic neurophysiology to a behavioral paradigm.

Authors:  Vincenzo Bonavita; Roberto De Simone; Angelo Ranieri
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 4.  Chronic migraine classification: current knowledge and future perspectives.

Authors:  Gian Camillo Manzoni; Vincenzo Bonavita; Gennaro Bussone; Pietro Cortelli; Maria Carola Narbone; Sabina Cevoli; Domenico D'Amico; Roberto De Simone; Paola Torelli
Journal:  J Headache Pain       Date:  2011-10-26       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.